Evidence also suggests that miR-16 interacts with the 3′-UTR of IGF1R, KRAS, and RAF1, thereby reducing osteosarcoma cell proliferation through the CRAF–MAPK pathway [156]. Here, RAF1 is linked to osteosarcoma.